[Paradoxical effect of levetiracetam on seizure suppression: three cases showing U curve association between dose and effect].
antiepileptic drug
focal epilepsy
paradoxical effect
serum concentration
Journal
Rinsho shinkeigaku = Clinical neurology
ISSN: 1882-0654
Titre abrégé: Rinsho Shinkeigaku
Pays: Japan
ID NLM: 0417466
Informations de publication
Date de publication:
21 Apr 2021
21 Apr 2021
Historique:
pubmed:
26
3
2021
medline:
23
9
2021
entrez:
25
3
2021
Statut:
ppublish
Résumé
We experienced 3 adult patients with intractable focal epilepsy treated by levetiracetam (LEV) as polytherapy, who showed paradoxical effect (PE). Starting dose of LEV was small (62.5, 250 mg/day) and we gradually increased by less than 250 mg/day, every more than 2 weeks. Within 6 months after LEV was added, LEV of 750 to 1,000 mg/day brought reduction of seizure frequency. Serum concentration of LEV was 13.3 and 14.0 μg/ml. In order to obtain better seizure control, LEV was increased up to 1,000-2,500 mg/day (19.3-35.0 μg/ml) within one year, and they developed PE. They all showed increased habitual seizures, occurring in cluster. Once dose of LEV deceased down to what produced the maximum seizure suppression, all of the patients regained the better seizure control. It is most likely that at least in some patients like present 3 cases, PE of LEV may express U curve association between dose and effect and that it was only delineated by slow titration.
Identifiants
pubmed: 33762498
doi: 10.5692/clinicalneurol.cn-001553
doi:
Substances chimiques
Anticonvulsants
0
Levetiracetam
44YRR34555
Types de publication
Case Reports
Journal Article
Langues
jpn
Sous-ensembles de citation
IM